These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29977074)

  • 21. The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
    Li CT; Chen MH; Lin WC; Hong CJ; Yang BH; Liu RS; Tu PC; Su TP
    Hum Brain Mapp; 2016 Mar; 37(3):1080-90. PubMed ID: 26821769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex.
    Zhang B; Yang X; Ye L; Liu R; Ye B; Du W; Shen F; Li Q; Guo F; Liu J; Guo F; Li Y; Xu Z; Liu Z
    Neuropharmacology; 2021 Aug; 194():108382. PubMed ID: 33144117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.
    Driesen NR; McCarthy G; Bhagwagar Z; Bloch MH; Calhoun VD; D'Souza DC; Gueorguieva R; He G; Leung HC; Ramani R; Anticevic A; Suckow RF; Morgan PT; Krystal JH
    Neuropsychopharmacology; 2013 Dec; 38(13):2613-22. PubMed ID: 23856634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
    Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
    Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.
    Napolitano A; Shah K; Schubert MI; Porkess V; Fone KC; Auer DP
    Schizophr Bull; 2014 May; 40(3):566-74. PubMed ID: 23671195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats.
    Tang H; Kukral D; Li YW; Fronheiser M; Malone H; Pena A; Pieschl R; Sidik K; Tobon G; Chow PL; Bristow LJ; Hayes W; Luo F
    J Psychopharmacol; 2018 Feb; 32(2):146-155. PubMed ID: 29378483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine.
    Radu D; Brodin E; Weber G; Lindefors N
    Brain Res; 2001 Jul; 908(2):197-203. PubMed ID: 11454330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
    Amat-Foraster M; Celada P; Richter U; Jensen AA; Plath N; Artigas F; Herrik KF
    Neuropharmacology; 2019 Nov; 158():107745. PubMed ID: 31445017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies.
    Pham TH; Gardier AM
    Pharmacol Ther; 2019 Jul; 199():58-90. PubMed ID: 30851296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia.
    Kim SY; Lee H; Kim HJ; Bang E; Lee SH; Lee DW; Woo DC; Choi CB; Hong KS; Lee C; Choe BY
    NMR Biomed; 2011 Dec; 24(10):1235-42. PubMed ID: 21560175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia.
    Krystal JH; Anand A; Moghaddam B
    Arch Gen Psychiatry; 2002 Jul; 59(7):663-4. PubMed ID: 12090822
    [No Abstract]   [Full Text] [Related]  

  • 38. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.
    Li N; Liu RJ; Dwyer JM; Banasr M; Lee B; Son H; Li XY; Aghajanian G; Duman RS
    Biol Psychiatry; 2011 Apr; 69(8):754-61. PubMed ID: 21292242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice.
    Lin JC; Lee MY; Chan MH; Chen YC; Chen HH
    Psychopharmacology (Berl); 2016 Sep; 233(17):3223-35. PubMed ID: 27363702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.